Presentations to Institutional Investors and Stock Analysts CUPERTINO, CA, March 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aemetis, Inc. (NASDAQ: AMTX) announced today that Chairman and CEO Eric McAfee will present to institutional investors and stock analysts at the Virtual 33rd Roth Capital Conference on March 15-17, 2021. The… Read More..

KZR-616 clinical development in three severe autoimmune diseases is advancing with several data readouts expected in 2021 and 2022, subject to developments in the ongoing COVID-19 pandemic. Upcoming poster presentations at AACR validate that inhibition of Sec61 with a small molecule can target multiple tumor types. Cash and cash equivalents… Read More..

Lexaria recently expanded its hypertension R&D program evaluating effectiveness of DehydraTECH-processed CBD to three human clinical studies and two animal studies KELOWNA, BC / ACCESSWIRE / March 11, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that CEO Chris… Read More..